Gabrielle Romain

Title: Gabrielle Romain: Innovator in Cytokine Signaling

Introduction

Gabrielle Romain is a notable inventor based in Berkeley, CA. She has made significant contributions to the field of cytokine signaling, particularly through her innovative patents. With a total of 3 patents, Romain's work focuses on advancing medical treatments and understanding complex biological processes.

Latest Patents

Romain's latest patents include "TGF-beta receptors and methods of use" and "Chimeric transmembrane proteins and uses thereof." The first patent provides engineered receptors involved in cytokine signaling, offering methods for modulating TGF-β signaling and treating cancer using chimeric antigen receptors. The second patent details chimeric transmembrane proteins, including nucleic acids encoding these proteins and methods for utilizing mammalian cells containing them.

Career Highlights

Gabrielle Romain is currently associated with Kite Pharma, Inc., where she continues to push the boundaries of research and innovation. Her work has the potential to impact cancer treatment significantly and improve patient outcomes.

Collaborations

Romain collaborates with talented individuals in her field, including Sarah Wyman and Peter Emtage. These partnerships enhance her research and contribute to the advancement of their shared goals.

Conclusion

Gabrielle Romain's contributions to cytokine signaling and her innovative patents position her as a key figure in the field of medical research. Her work at Kite Pharma, Inc. exemplifies the impact of dedicated inventors in advancing healthcare solutions.